CCBR

Calcium Channel Blockers Revisited

Robert C. Schlant, MD Professor of Medicine Emory University School of Medicine Chief of Cardiology Grady Memorial Hospital Atlanta, Georgia	Introduction The Safety Controversy Treating the Elderly Hypertensive Patient
Robert W. Piepho, PhD Dean and Professor School of Pharmacy University of Missouri-Kansas City Kansas City, Missouri	Pharmacology of the Calcium Channel Blockers Distinct Binding Sites Selectivity of Action Pharmacokinetics Metabolic Effects Hemodynamic Differentiation Adverse Effects Summary
William E. Boden, MD Professor of Medicine Boston University School of Medicine Director, Ischemic Heart Disease Research Department of Veterans Affairs Medical Center Boston, Massachusetts	Antihypertensive Agents and Cardiovascular Risk: Toward a Balanced Perspective Risk of First MI in Hypertensive patients Risk of Mortality with Calcium Channel Blockers in CHD Patients Risk of Mortality with Nondihydropyridine Agents Risk of Sudden Cardiac Death with Beta Blockers and Diuretucs Conclusions
William B. Applegate, MD Professor and Chairman Department of Preventive Medicine University of Tennessee Memphis, Tennessee	Selecting Antihypertensive Therapy for Elderly Patients: Considering Averages and Individuals Results from Clinical Trials Factors Affecting Choice of Antihypertensive Therapy Differential Effects of Antihypertensive Agents Quality of Life Compliance Issues
	CME Information/Questions Slide Presentation